ArticleJournal of gastrointestinal oncology2024
Regorafenib with or without chemotherapy/immunotherapy in second-line treatment of metastatic colorectal cancer during the COVID-19 pandemic: a single-center retrospective analysis.
Yu Xiao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.